Annual Reports in Medicinal Chemistry
短名 | Annu. Rep. Med. Chem. |
Journal Impact | 2.67 |
期刊索引 | 中科院 4 区 |
ISSN | 0065-7743, 1557-8437 |
h-index | |
国内分区 | 化学(4区)化学药物化学(4区)化学药学(4区) |
药物化学年度报告对药物化学中的重要主题提供及时和批判性的评论,重点是生物科学中的新兴主题,这些主题有望为全新的未来疗法提供基础。
期刊主页涉及主题 | 生物化学医学生物化学遗传学内科学药理学心理学有机化学内分泌学物理精神科受体核磁共振 |
出版信息 | 出版商: Academic Press Inc.,出版周期: Irregular,期刊类型: book-series |
基本数据 | 创刊年份: 2017,原创研究文献占比: 0.00%,自引率:N.A., Gold OA占比: 0.00% |
平均审稿周期 | 网友分享经验:>12周,或约稿 |
平均录用比例 | 网友分享经验:较易 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Pharmacology of marine drugs: Pattern-, purpose- and prudence-driven innovations
2023-1-1
Series Page
2023-1-1
Nucleoside-derived inhibitors of MraY: Medicinal chemistry with natural products
2023-1-1
Bacterial metalloproteases as promising drug targets for antivirulence agents
2023-1-1
Chemical evolution of natural product structure for drug discovery
2023-1-1
Advances in natural products driven drug discovery from medicinal plants for neuropathic pain
2023-1-1
Copyright
2023-1-1
Preface
2023-1-1
Copyright
2023-1-1
Targeting the bacterial β-sliding clamp (DnaN): A promising strategy for novel antibiotics
2023-1-1
Quo vadis quorum sensing? Advances in disrupting the Pseudomonas quinolone signal (PQS)
2023-1-1
Contributors
2023-1-1
Series Page
2023-1-1
New Approaches Towards Novel Antibacterial Agents
2023-1-1
The challenges and opportunities of developing small molecule inhibitors of MraY
2023-1-1
The polypharmacology of natural products in drug discovery and development
2023-1-1
Natural Products
2023-1-1
Inhibitors of the bacterial enzyme MurA as potential novel antibiotics
2023-1-1
Contributors
2023-1-1
Preface
2023-1-1
Using filters in virtual screening: A comprehensive guide to minimize errors and maximize efficiency
2022-1-1
Discovery of small molecule antivirals targeting tick-borne encephalitis virus
2022-1-1
Copyright
2022-1-1
Contributors
2022-1-1
Series Page
2022-1-1
Virtual Screening and Drug Docking
2022-1-1
No dance, no partner! A tale of receptor flexibility in docking and virtual screening
2022-1-1
Animal models of tick-borne encephalitis for preclinical antiviral research
2022-1-1
Can docking scoring functions guarantee success in virtual screening?
2022-1-1
Perylene as a controversial antiviral scaffold
2022-1-1
Copyright
2022-1-1
Series Page
2022-1-1
Preface
2022-1-1
Small molecule-based inhibitors for treatment of tick-borne encephalitis virus infection: Nucleoside analogs and nonnucleoside antivirals
2022-1-1
Medicinal Chemistry of Tick-Borne Encephalitis
2022-1-1
Preface
2022-1-1
Contributors
2022-1-1
Virtual screening against Mycobacterium tuberculosis DNA gyrase: Applications and success stories
2022-1-1
Rational computational approaches to predict novel drug candidates against leishmaniasis
2022-1-1
Insights from experience in the treatment of tick-borne bacterial coinfections with tick-borne encephalitis
2022-1-1
Chemistry perspectives of reversible covalent drugs
2021-1-1
Copyright
2021-1-1
Coronaviruses and other Novel Antiviral Targets
2021-1-1
Design of next-generation covalent inhibitors: Targeting residues beyond cysteine
2021-1-1
Contributors
2021-1-1
The search for antivirals to treat alphavirus infections
2021-1-1
Uracil derivatives as non-nucleoside inhibitors of viral infections
2021-1-1
Computational support of structure-based targeted covalent inhibitor design
2021-1-1
Covalent fragment screening
2021-1-1
Series Page
2021-1-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远